We are live on ! Find out more
LC

Lindbrook Capital Portfolio holdings

AUM $1.08B
1-Year Est. Return 10.14%
This Fund
S&P 500
This Quarter Est. Return
+7.83%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
–
AUM
$853M
AUM Growth
+$41.2M
Cap. Flow
-$4.27M
Cap. Flow %
-0.5%
Top 10 Hldgs %
45.97%
Holding
2,993
New
166
Increased
1,040
Reduced
961
Closed
220

Top Buys

Rank Stock Value
1
VXUS icon
Vanguard Total International Stock ETF
VXUS
+$12.7M
2
RPAR icon
RPAR Risk Parity ETF
RPAR
+$5.28M
3
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$4.15M
4
BAC icon
Bank of America
BAC
+$4.06M
5
NVDA icon
NVIDIA
NVDA
+$3.33M

Top Sells

Rank Stock Value
1
ORMP icon
Oramed Pharmaceuticals
ORMP
+$4.61M
2
DBC icon
Invesco DB Commodity Index Tracking Fund
DBC
+$4.54M
3
FTGC icon
First Trust Global Tactical Commodity Strategy Fund
FTGC
+$4.45M
4
IEO icon
iShares US Oil & Gas Exploration & Production ETF
IEO
+$4.15M
5
AGEN
Agenus
AGEN
+$2.89M

Sector Composition

Rank Sector Weight
1 Financials 17.04%
2 Technology 13.3%
3 Healthcare 7.37%
4 Industrials 3.43%
5 Consumer Staples 3.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IMDX
2751
Insight Molecular Diagnostics
IMDX
$156M
$30 ﹤0.01%
4
– –
WCLD
2752
WisdomTree Cloud Computing Fund
WCLD
$297M
$30 ﹤0.01%
1
– –
MP icon
2753
MP Materials
MP
$9.1B
$28 ﹤0.01%
1
-77
-99% -$2.33K
FREL icon
2754
Fidelity MSCI Real Estate Index ETF
FREL
$1.49B
$25 ﹤0.01%
1
– –
HIPO.WS
2755
DELISTED
Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share
HIPO.WS
$25 ﹤0.01%
450
– –
FBIO icon
2756
Fortress Biotech
FBIO
$88.7M
$24 ﹤0.01%
2
– –
APPH
2757
DELISTED
AppHarvest, Inc. Common Stock
APPH
$24 ﹤0.01%
40
– –
BLOK icon
2758
Amplify Blockchain Technology ETF
BLOK
$1.07B
$19 ﹤0.01%
1
– –
FG icon
2759
F&G Annuities & Life
FG
$3.62B
$18 ﹤0.01%
1
-80
-99% -$1.6K
PXH icon
2760
Invesco FTSE RAFI Emerging Markets ETF
PXH
$1.96B
$18 ﹤0.01%
1
– –
AKO.B icon
2761
Embotelladora Andina Series B
AKO.B
$4.95B
$16 ﹤0.01%
1
– –
ETON icon
2762
Eton Pharmaceutcials
ETON
$1.22B
$15 ﹤0.01%
4
– –
GTX icon
2763
Garrett Motion
GTX
$5.57B
$15 ﹤0.01%
2
– –
SWBI icon
2764
Smith & Wesson
SWBI
$637M
$12 ﹤0.01%
1
– –
ITCL
2765
DELISTED
Banco Itau Chile American Depositary Shares (each representing one third of one (1/3) Common Share)
ITCL
$4 ﹤0.01%
1
– –
FABC
2766
Fabric.AI Inc
FABC
$18.4M
– –
0
– –
SPPI
2767
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$1 ﹤0.01%
1
– –
ACRS icon
2768
Aclaris Therapeutics
ACRS
$869M
– –
-208
Closed -$3.28K
ADV icon
2769
Advantage Solutions
ADV
$361M
– –
-118
Closed -$6.12K
AFMD
2770
DELISTED
Affimed
AFMD
– –
-17
Closed -$216
AGG icon
2771
iShares Core US Aggregate Bond ETF
AGG
$138B
– –
-1,557
Closed -$151K
ALEC icon
2772
Alector
ALEC
$199M
– –
-271
Closed -$2.5K
ALXO icon
2773
ALX Oncology
ALXO
$290M
– –
-215
Closed -$2.42K
AMN icon
2774
AMN Healthcare
AMN
$1.4B
– –
-79
Closed -$8.12K
AMPL icon
2775
Amplitude
AMPL
$1.41B
– –
-13
Closed -$157
109 110
111
112 113

Similar funds

SBIA
Sheaff Brock Investment Advisors Indianapolis, Indiana $1.09B AUM 14.4% 1-Year Est. Return
CHP
Cable Hill Partners Portland, Oregon $1.02B AUM 8.59% 1-Year Est. Return
MW
Marcum Wealth Cleveland, Ohio $1.16B AUM 6.7% 1-Year Est. Return
TAM
Taurus Asset Management New York $986M AUM 5.04% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.72% 1-Year Est. Return
CIG
CCM Investment Group Northfield, Minnesota $946M AUM
CCM
CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return
WCF
West Coast Financial Santa Barbara, California $876M AUM 5.74% 1-Year Est. Return

Lindbrook Capital's Q1 2023 Portfolio in Review

As of Q1 2023, Lindbrook Capital held 2,993 positions worth $853M, up 5.1% from $812M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Lindbrook Capital's Q1 2023 filing shows 166 new, 1,040 increased, 961 reduced and 220 closed positions. Its largest new stake was Hess Midstream: 4,984 shares worth $144K. The largest sale was Oramed Pharmaceuticals, an estimated $4.61M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 18% a quarter earlier, followed by Technology and Healthcare.

  • Lindbrook Capital's largest Q1 2023 buy was Hess Midstream: 4,984 shares worth $144K.
  • Lindbrook Capital added most to Vanguard Total International Stock ETF in Q1 2023, an estimated $12.7M increase.
  • Lindbrook Capital's biggest Q1 2023 reduction was Agenus, cutting an estimated $2.89M.
  • Lindbrook Capital fully exited Oramed Pharmaceuticals in Q1 2023, selling an estimated $4.61M.
  • Lindbrook Capital's ten largest holdings make up 46% of its $853M portfolio in Q1 2023.
  • Lindbrook Capital opened 166 new positions and closed 220 in Q1 2023.
  • Lindbrook Capital's portfolio value rose 5.1% quarter-over-quarter to $853M.

Based on Lindbrook Capital's 13F filing for Q1 2023, filed 26 Apr 2023.